These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2282933)
1. Effects of cromakalim, a potassium channel opener, on regional blood flow in conscious spontaneously hypertensive rats. Shoji T; Aki Y; Fukui K; Tamaki T; Iwao H; Abe Y Eur J Pharmacol; 1990 Sep; 186(1):119-23. PubMed ID: 2282933 [TBL] [Abstract][Full Text] [Related]
2. Preclinical pharmacology of Ro 31-6930, a new potassium channel opener. Paciorek PM; Burden DT; Burke YM; Cowlrick IS; Perkins RS; Taylor JC; Waterfall JF J Cardiovasc Pharmacol; 1990 Feb; 15(2):188-97. PubMed ID: 1689412 [TBL] [Abstract][Full Text] [Related]
3. Increased vasodilator responsiveness to BRL 34915 in spontaneously hypertensive versus normotensive rats: contrast with nifedipine. Falotico R; Keiser J; Haertlein B; Cheung WM; Tobia A Proc Soc Exp Biol Med; 1989 Feb; 190(2):179-85. PubMed ID: 2915996 [TBL] [Abstract][Full Text] [Related]
4. A comparison of the haemodynamic profiles of Ro 31-6930, cromakalim and nifedipine in anaesthetised normotensive rats. Duty S; Paciorek PM; Waterfall JF; Weston AH Eur J Pharmacol; 1990 Aug; 185(1):35-42. PubMed ID: 2226633 [TBL] [Abstract][Full Text] [Related]
5. Preferential small arteriolar vasodilatation by the potassium channel opener, BRL 38227, in conscious spontaneously hypertensive rats. Struijker Boudier HA; Messing MW; van Essen H Eur J Pharmacol; 1992 Jul; 218(1):191-3. PubMed ID: 1397031 [TBL] [Abstract][Full Text] [Related]
6. Effects of a K+ATP channel opener, lemakalim, on systemic, coronary and regional vascular dynamics in conscious dogs: comparison with nifedipine, adenosine, nitroglycerin and acetylcholine. Shen YT; Vatner SF J Pharmacol Exp Ther; 1993 May; 265(2):1026-37. PubMed ID: 8496801 [TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts. D'Alonzo AJ; Grover GJ; Darbenzio RB; Sewter JC; Hess TA; Dzwonczyk S; Sleph PG Pharmacology; 1996 Feb; 52(2):101-12. PubMed ID: 8851631 [TBL] [Abstract][Full Text] [Related]
8. Systemic and regional haemodynamic interactions between K+ channel openers and the sympathetic nervous system in the pithed SHR. Richer C; Mulder P; Doussau MP; Gautier P; Giudicelli JF Br J Pharmacol; 1990 Jul; 100(3):557-63. PubMed ID: 2390680 [TBL] [Abstract][Full Text] [Related]
9. BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. Buckingham RE; Clapham JC; Hamilton TC; Longman SD; Norton J; Poyser RH J Cardiovasc Pharmacol; 1986; 8(4):798-804. PubMed ID: 2427821 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin. Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827 [TBL] [Abstract][Full Text] [Related]
11. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models. Clapham JC; Hamilton TC; Longman SD; Buckingham RE; Campbell CA; Ilsley GL; Gout B Arzneimittelforschung; 1991 Apr; 41(4):385-91. PubMed ID: 1907150 [TBL] [Abstract][Full Text] [Related]
12. Cromakalim does not protect against skeletal muscle fatigue in an anaesthetized rat model of acute hindlimb ischaemia. Trezise DJ; Drew GM; Roach AG; Watts IS; Weston AH Eur J Pharmacol; 1993 Nov; 250(1):109-16. PubMed ID: 8119308 [TBL] [Abstract][Full Text] [Related]
13. Effect of short-term administration of cromakalim on renal hemodynamics and eicosanoid excretion in essential hypertension. Lebel M; Grose JH; Lacourcière Y Am J Hypertens; 1991 Sep; 4(9):740-4. PubMed ID: 1834087 [TBL] [Abstract][Full Text] [Related]
14. Haemodynamic differences between cromakalim and pinacidil: comparison with nifedipine. Clapham JC; Longman SD Eur J Pharmacol; 1989 Nov; 171(1):109-17. PubMed ID: 2693121 [TBL] [Abstract][Full Text] [Related]
15. Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine. Buckingham RE Br J Pharmacol; 1988 Mar; 93(3):541-52. PubMed ID: 3370388 [TBL] [Abstract][Full Text] [Related]